Search Results

Filter
  • 1-10 of  29,728 results for ""Bevacizumab""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate-stage hepatocellular carcinoma.

Subjects: Bevacizumab*/Bevacizumab*/Bevacizumab*/therapeutic use ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/drug therapy

  • Source: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2024 Jan; Vol. 44 (1), pp. 113-124. Date of Electronic Publication: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Clinical outcomes and medical resource utilization of toripalimab combination therapy versus bevacizumab plus chemotherapy in advanced non-squamous non-small cell lung cancer.

  • Authors : Qi H; Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China.; Zhang W

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Bevacizumab*/Bevacizumab*/Bevacizumab*/therapeutic use ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy

  • Source: Current medical research and opinion [Curr Med Res Opin] 2024 Mar; Vol. 40 (3), pp. 441-453. Date of Electronic Publication: 2024 Jan 22.Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Use of bevacizumab in a patient with Whipple's disease: managing diagnostic uncertainty.

  • Authors : Tjandra DP; Department of Gastroenterology, The Royal Melbourne Hospital City Campus, Parkville, Victoria, Australia.; Brett A

Subjects: Bevacizumab*/Bevacizumab*/Bevacizumab*/therapeutic use ; Whipple Disease*/Whipple Disease*/Whipple Disease*/drug therapy ; Whipple Disease*/Whipple Disease*/Whipple Disease*/pathology

  • Source: BMJ case reports [BMJ Case Rep] 2023 Oct 24; Vol. 16 (10). Date of Electronic Publication: 2023 Oct 24.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101526291 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-790X

Record details

×
Report

Bevacizumab-induced arrhythmia in a patient with lung adenocarcinoma: A case report.

  • Authors : Li J; Department of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Zhang F

Subjects: Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/adverse effects ; Arrhythmias, Cardiac*/Arrhythmias, Cardiac*/Arrhythmias, Cardiac*/chemically induced ; Arrhythmias, Cardiac*/Arrhythmias, Cardiac*/Arrhythmias, Cardiac*/diagnosis

  • Source: Medicine [Medicine (Baltimore)] 2023 Sep 01; Vol. 102 (35), pp. e34799.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Prospective validation of VEGF and eNOS polymorphisms as predictors of first-line bevacizumab efficacy in patients with metastatic colorectal cancer.

  • Authors : Marisi G; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Azzali I

Subjects: Bevacizumab*/Bevacizumab*/Bevacizumab*/therapeutic use ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/drug therapy ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/genetics

  • Source: Scientific reports [Sci Rep] 2023 Aug 09; Vol. 13 (1), pp. 12921. Date of Electronic Publication: 2023 Aug 09.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Comparison of Optical Coherence Tomography Biomarkers between Bevacizumab Good Responders and Nonresponders Who were Switched to Dexamethasone Implant in Diabetic Macular Edema.

  • Authors : Lee JH; Department of Ophthalmology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.; Shin JY

Subjects: Bevacizumab*/Bevacizumab*/Bevacizumab*/therapeutic use ; Dexamethasone*/Dexamethasone*/Dexamethasone*/therapeutic use ; Diabetes Mellitus*

  • Source: Korean journal of ophthalmology : KJO [Korean J Ophthalmol] 2023 Apr; Vol. 37 (2), pp. 137-146. Date of Electronic Publication: 2023 Mar 23.Publisher: KJO Country of Publication: Korea (South) NLM ID: 8804513 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2092-9382

Record details

×
Academic Journal

A Randomized, Double-Blind, Parallel-Controlled Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of SCT510 to Bevacizumab (Avastin ® ) in Healthy Chinese Males.

  • Authors : Wu J; Research Center of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Zhejiang University School of Medicine, Hangzhou, China.

Subjects: Bevacizumab*/Bevacizumab*/Bevacizumab*/pharmacokinetics ; Biosimilar Pharmaceuticals*; Humans

  • Source: Drugs in R&D [Drugs R D] 2023 Jun; Vol. 23 (2), pp. 175-183. Date of Electronic Publication: 2023 May 29.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100883647 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Characteristics of macular edema associated with retinal vein occlusion showing poor anatomic response to three loading anti-vascular endothelial growth factor injections: an optical coherence tomography analysis.

  • Authors : Johari M; Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. .; Attar A

Subjects: Macular Edema*/Macular Edema*/Macular Edema*/diagnosis ; Macular Edema*/Macular Edema*/Macular Edema*/drug therapy ; Macular Edema*/Macular Edema*/Macular Edema*/etiology

  • Source: BMC ophthalmology [BMC Ophthalmol] 2024 Jan 22; Vol. 24 (1), pp. 30. Date of Electronic Publication: 2024 Jan 22.Publisher: BioMed Central Country of Publication: England NLM ID: 100967802 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2415

Record details

×
  • 1-10 of  29,728 results for ""Bevacizumab""